form_10q.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM
10-Q
(Mark
One)
X QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF
1934
For
the quarterly period ended March 31, 2009
or
___ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF
1934
For
the transition period from _______________ to _______________
Commission
file number 1-11316
OMEGA
HEALTHCARE
INVESTORS,
INC.
(Exact
name of Registrant as specified in its charter)
|
|
|
|
Maryland
|
|
38-3041398
|
(State
of incorporation)
|
|
(IRS
Employer
Identification
No.)
|
|
200
International Circle, Suite 3500, Hunt Valley, MD 21030
|
(Address
of principal executive offices)
|
|
(410)
427-1700
|
(Telephone
number, including area code)
|
Indicate by check mark whether the
registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports) and
(2) has been subject to such filing requirements for the past 90
days.
Yes x No o
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding
12 months (or for such shorter period that the registrant was required to submit
and post such files).
Yes o No o [NOT
APPLICABLE]
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, or
non-accelerated filer. See definition of “accelerated filer and large
accelerated filer” in Rule 12b-2 of the Exchange Act. (Check
one:)
Large accelerated
filer x Accelerated
filer o Non-accelerated
filer o Small reporting
company o
Indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).
Yes o No x
Indicate the number of shares
outstanding of each of the issuer's classes of common stock as of April 30,
2009.
Common Stock, $.10 par
value 82,408,075
(Class)
(Number of shares)
OMEGA
HEALTHCARE INVESTORS, INC.
FORM
10-Q
March
31, 2009
|
|
|
Page No.
|
PART I
|
Financial Information
|
|
|
|
|
Item
1.
|
Financial
Statements:
|
|
|
|
|
|
March 31, 2009 (unaudited) and
December 31,
2008
|
2
|
|
|
|
|
|
|
|
Three months ended March 31, 2009
and
2008
|
3
|
|
|
|
|
|
|
|
Three months ended March 31, 2009
and
2008
|
4
|
|
|
|
|
|
|
|
March 31, 2009
(unaudited)
|
5
|
|
|
|
Item
2.
|
|
15 |
|
|
|
Item
3.
|
|
25
|
|
|
|
Item
4.
|
|
25
|
|
|
|
PART II
|
Other Information
|
|
|
|
|
Item
1.
|
|
26
|
|
|
|
Item
1A.
|
|
26
|
|
|
|
Item
6.
|
|
26
|
|
|
|
PART
I – FINANCIAL INFORMATION
Item
1 - Financial Statements
OMEGA
HEALTHCARE INVESTORS, INC.
(in thousands, except per share
amounts)
|
|
March
31,
|
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(Unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
Real
estate properties
|
|
|
|
|
|
|
Land and
buildings
|
|
$ |
1,375,132 |
|
|
$ |
1,372,012 |
|
Less accumulated
depreciation
|
|
|
(262,762 |
) |
|
|
(251,854 |
) |
Real estate properties –
net
|
|
|
1,112,370 |
|
|
|
1,120,158 |
|
Mortgage notes receivable –
net
|
|
|
100,726 |
|
|
|
100,821 |
|
|
|
|
1,213,096 |
|
|
|
1,220,979 |
|
Other
investments – net
|
|
|
26,922 |
|
|
|
29,864 |
|
|
|
|
1,240,018 |
|
|
|
1,250,843 |
|
Assets
held for sale – net
|
|
|
80 |
|
|
|
150 |
|
Total
investments
|
|
|
1,240,098 |
|
|
|
1,250,993 |
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
|
10,215 |
|
|
|
209 |
|
Restricted
cash
|
|
|
6,447 |
|
|
|
6,294 |
|
Accounts
receivable – net
|
|
|
77,035 |
|
|
|
75,037 |
|
Other
assets
|
|
|
14,742 |
|
|
|
18,613 |
|
Operating
assets for owned and operated properties
|
|
|
6,265 |
|
|
|
13,321 |
|
Total assets
|
|
$ |
1,354,802 |
|
|
$ |
1,364,467 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Revolving
line of credit
|
|
$ |
55,000 |
|
|
$ |
63,500 |
|
Unsecured
borrowings – net
|
|
|
484,693 |
|
|
|
484,697 |
|
Accrued
expenses and other liabilities
|
|
|
26,777 |
|
|
|
25,420 |
|
Operating
liabilities for owned and operated properties
|
|
|
1,783 |
|
|
|
2,862 |
|
Total
liabilities
|
|
|
568,253 |
|
|
|
576,479 |
|
|
|
|
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
Preferred stock issued and
outstanding – 4,340 shares Series D with an aggregate liquidation
preference of $108,488
|
|
|
108,488 |
|
|
|
108,488 |
|
Common stock $.10 par value authorized – 100,000 shares: issued and
outstanding – 82,408 shares as of March 31, 2009 and 82,382 as of December
31, 2008
|
|
|
8,241 |
|
|
|
8,238 |
|
Common
stock – additional paid-in-capital
|
|
|
1,054,838 |
|
|
|
1,054,157 |
|
Cumulative
net earnings
|
|
|
465,189 |
|
|
|
440,277 |
|
Cumulative
dividends paid
|
|
|
(850,207 |
) |
|
|
(823,172 |
) |
Total stockholders’
equity
|
|
|
786,549 |
|
|
|
787,988 |
|
Total liabilities and
stockholders’ equity
|
|
$ |
1,354,802 |
|
|
$ |
1,364,467 |
|
See notes
to consolidated financial statements.
OMEGA
HEALTHCARE INVESTORS, INC.
Unaudited
(in
thousands, except per share amounts)
|
|
Three
Months Ended
|
|
|
|
March
31,
|
|
|
|
2009
|
|
|
2008
|
|
Revenues
|
|
|
|
|
|
|
Rental
income
|
|
$ |
41,175 |
|
|
$ |
38,013 |
|
Mortgage interest
income
|
|
|
2,876 |
|
|
|
979 |
|
Other investment income –
net
|
|
|
611 |
|
|
|
636 |
|
Miscellaneous
|
|
|
74 |
|
|
|
1,238 |
|
Nursing home revenues of owned
and operated
assets
|
|
|
4,424 |
|
|
|
- |
|
Total
operating
revenues
|
|
|
49,160 |
|
|
|
40,866 |
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
10,931 |
|
|
|
9,396 |
|
General and
administrative
|
|
|
3,159 |
|
|
|
3,094 |
|
Impairment loss on real estate
properties
|
|
|
70 |
|
|
|
1,514 |
|
Nursing home expenses of owned and
operated
assets
|
|
|
5,353 |
|
|
|
- |
|
Total
operating
expenses
|
|
|
19,513 |
|
|
|
14,004 |
|
|
|
|
|
|
|
|
|
|
Income
before other income and
expense
|
|
|
29,647 |
|
|
|
26,862 |
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
Interest
income
|
|
|
11 |
|
|
|
65 |
|
Interest
expense
|
|
|
(8,773 |
) |
|
|
(9,685 |
) |
Interest – amortization of
deferred financing
costs
|
|
|
(500 |
) |
|
|
(500 |
) |
Litigation
settlements
|
|
|
4,527 |
|
|
|
- |
|
Total
other
expense
|
|
|
(4,735 |
) |
|
|
(10,120 |
) |
|
|
|
|
|
|
|
|
|
Income
before gain on assets
sold
|
|
|
24,912 |
|
|
|
16,742 |
|
Gain
on assets sold –
net
|
|
|
- |
|
|
|
46 |
|
Income
from continuing
operations
|
|
|
24,912 |
|
|
|
16,788 |
|
Discontinued
operations
|
|
|
- |
|
|
|
446 |
|
Net
income
|
|
|
24,912 |
|
|
|
17,234 |
|
Preferred
stock
dividends
|
|
|
(2,271 |
) |
|
|
(2,481 |
) |
Net
income available to common
shareholders
|
|
$ |
22,641 |
|
|
$ |
14,753 |
|
|
|
|
|
|
|
|
|
|
Income
per common share available to common shareholders:
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
Income from continuing
operations
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Net
income
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Diluted:
|
|
|
|
|
|
|
|
|
Income from continuing
operations
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Net
income
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
|
|
|
|
|
|
|
|
|
Dividends
declared and paid per common
share
|
|
$ |
0.30 |
|
|
$ |
0.29 |
|
|
|
|
|
|
|
|
|
|
Weighted-average
shares outstanding,
basic
|
|
|
82,396 |
|
|
|
68,680 |
|
Weighted-average
shares outstanding,
diluted
|
|
|
82,478 |
|
|
|
68,747 |
|
|
|
|
|
|
|
|
|
|
Components
of other comprehensive income:
|
|
|
|
|
|
|
|
|
Net
income
|
|
$ |
24,912 |
|
|
$ |
17,234 |
|
Total
comprehensive
income
|
|
$ |
24,912 |
|
|
$ |
17,234 |
|
See notes to consolidated financial
statements.
OMEGA
HEALTHCARE INVESTORS, INC.
Unaudited
(in thousands)
|
|
Three
Months Ended
March
31,
|
|
|
|
2009
|
|
|
2008
|
|
Cash
flows from operating activities
|
|
|
|
|
|
|
Net
income
|
|
$ |
24,912 |
|
|
$ |
17,234 |
|
Adjustment to reconcile net
income to cash provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
(including amounts in discontinued operations)
|
|
|
10,931 |
|
|
|
9,396 |
|
Impairment loss on real estate
properties (including amounts in discontinued operations)
|
|
|
70 |
|
|
|
1,514 |
|
Amortization of deferred
financing costs
|
|
|
500 |
|
|
|
500 |
|
(Gains) losses on assets sold
and equity securities – net
|
|
|
— |
|
|
|
(477 |
) |
Restricted stock amortization
expense
|
|
|
480 |
|
|
|
526 |
|
Income from accretion of
marketable securities to redemption value
|
|
|
— |
|
|
|
(52 |
) |
Other
|
|
|
(43 |
) |
|
|
(47 |
) |
Change
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(177 |
) |
|
|
746 |
|
Straight-line
rent
|
|
|
(2,391 |
) |
|
|
(1,869 |
) |
Lease
inducement
|
|
|
570 |
|
|
|
818 |
|
Other
operating assets and liabilities
|
|
|
4,568 |
|
|
|
188 |
|
Operating
assets and liabilities for owned and operated properties
|
|
|
5,977 |
|
|
|
— |
|
Net
cash provided by operating activities
|
|
|
45,397 |
|
|
|
28,477 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities
|
|
|
|
|
|
|
|
|
Acquisition
of real estate
|
|
|
— |
|
|
|
(5,200 |
) |
Proceeds
from sale of real estate investments
|
|
|
— |
|
|
|
3,027 |
|
Capital
improvements and funding of other investments
|
|
|
(3,120 |
) |
|
|
(5,334 |
) |
Proceeds
from other investments
|
|
|
16,803 |
|
|
|
2,779 |
|
Investments
in other investments
|
|
|
(13,855 |
) |
|
|
(5,004 |
) |
Collection
of mortgage principal – net
|
|
|
133 |
|
|
|
222 |
|
Net
cash used in investing activities
|
|
|
(39 |
) |
|
|
(9,510 |
) |
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities
|
|
|
|
|
|
|
|
|
Proceeds
from credit facility borrowings
|
|
|
34,000 |
|
|
|
74,300 |
|
Payments
on credit facility borrowings
|
|
|
(42,500 |
) |
|
|
(40,300 |
) |
Payments
of other long-term borrowings
|
|
|
— |
|
|
|
(39,000 |
) |
Receipts
from dividend reinvestment plan
|
|
|
183 |
|
|
|
10,096 |
|
Payments
from exercised options and taxes on restricted stock – net
|
|
|
— |
|
|
|
(2,087 |
) |
Dividends
paid
|
|
|
(27,035 |
) |
|
|
(22,439 |
) |
Net
cash used in financing activities
|
|
|
(35,352 |
) |
|
|
(19,430 |
) |
|
|
|
|
|
|
|
|
|
Increase
(decrease) in cash and cash equivalents
|
|
|
10,006 |
|
|
|
(463 |
) |
Cash
and cash equivalents at beginning of period
|
|
|
209 |
|
|
|
1,979 |
|
Cash
and cash equivalents at end of period
|
|
$ |
10,215 |
|
|
$ |
1,516 |
|
Interest
paid during the period, net of amounts capitalized
|
|
$ |
6,474 |
|
|
$ |
7,437 |
|
See notes
to consolidated financial statements.
OMEGA
HEALTHCARE INVESTORS, INC.
Unaudited
March
31, 2009
NOTE
1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Business
Overview:
We have one reportable segment
consisting of investments in healthcare related real estate
properties. Our core business is to provide financing and capital to
the long-term healthcare industry with a particular focus on skilled nursing
facilities located in the United States. Our core portfolio consists
of long-term leases and mortgage agreements. All of our leases are
“triple-net” leases, which require the tenants to pay all property-related
expenses. Our mortgage revenue derives from fixed-rate mortgage
loans, which are secured by first mortgage liens on the underlying real estate
and personal property of the mortgagor. In July 2008, we assumed
operating responsibilities for 15 of our facilities due to the bankruptcy of one
of our operator/tenants. In September 2008, we entered into an
agreement to lease these facilities to a new operator/tenant. The new
operator/tenant assumed operating responsibility for 13 of the 15 facilities
effective September 1, 2008. We continue to be
responsible for the two remaining facilities as of March 31, 2009 that are in
the process of being transitioned to the new operator pending approval by state
regulators. Substantially all depreciation expenses reflected in the
consolidated statements of income relate to the ownership of our investment in
real estate.
Basis
of Presentation:
The accompanying unaudited consolidated
financial statements for Omega Healthcare Investors, Inc. (“Omega” or the
“Company”) have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission regarding interim financial information and
with the instructions to Form 10-Q and Article 10 of Regulation
S-X. Accordingly, they do not include all of the information and
notes required by generally accepted accounting principles (“GAAP”) in the
United States for complete financial statements. In our opinion, all
adjustments (consisting of normal recurring accruals) considered necessary for a
fair presentation have been included. These unaudited consolidated
financial statements should be read in conjunction with the financial statements
and the footnotes thereto included in our latest Annual Report on Form
10-K.
Our
consolidated financial statements include the accounts of Omega, all direct and
indirect wholly owned subsidiaries; as well as TC Healthcare I, LLC. (“TC
Healthcare”), an entity and interim operator created to operate the 15
facilities we assumed as a result of the bankruptcy of one our
tenant/operators. We consolidate the financial results of TC
Healthcare into our financial statements based on the application of the
applicable consolidation accounting literature. We include the
operating results and assets and liabilities of these facilities for the period
of time that TC Healthcare was responsible for the operations of the
facilities. Thirteen of these facilities were transitioned from TC
Healthcare to a new tenant/operator on September 1, 2008, however, TC Healthcare
continues to be responsible for two facilities as of March 31, 2009 that are in
the process of being transitioned to the new operator/tenant pending approval by
state regulators. The operating revenues and expenses and related
operating assets and liabilities of the owned and operated facilities are shown
on a gross basis in our Consolidated Statements of Income and Consolidated
Balance Sheets, respectively. All inter-company accounts and
transactions have been eliminated in consolidation of the financial
statements.
Reclassifications:
Certain amounts in the prior year have
been reclassified to conform to the current year presentation and to reflect the
results of discontinued operations. See Note 10 – Discontinued Operations for a
discussion of discontinued operations. Such reclassifications have no
effect on previously reported earnings or equity.
Accounts
Receivable:
Accounts
receivable includes: contractual receivables, straight-line rent receivables,
lease inducements, net of an estimated provision for losses related to
uncollectible and disputed accounts. Contractual receivables relate
to the rents currently owed to us under the terms of the lease
agreement. Straight-line receivables relates to the difference
between the rental revenue recognized on a straight-line basis and the amounts
due to us contractually. Lease inducements result from value provided
by us to the lessee of the lease and will be amortized as a reduction of rental
revenue over the lease term. On a quarterly basis, we review the
collection of our contractual payments and determine the appropriateness of our
allowance for uncollectible contractual rents. In the case of a lease
recognized on a straight-line basis, we generally provide an allowance for
straight-line accounts receivable when certain conditions or indicators of
adverse collectibility are present.
A summary
of our net receivables by type is as follows:
|
|
March
31,
2009
|
|
|
December
31, 2008
|
|
|
|
(in
thousands)
|
|
|
|
|
|
|
|
|
Contractual
receivables
|
|
$ |
2,626 |
|
|
$ |
2,358 |
|
Straight-line
receivables
|
|
|
45,999 |
|
|
|
43,636 |
|
Lease
inducements
|
|
|
29,990 |
|
|
|
30,561 |
|
Allowance
|
|
|
(1,580 |
) |
|
|
(1,518 |
) |
Accounts
receivable –
net
|
|
$ |
77,035 |
|
|
$ |
75,037 |
|
We
continuously evaluate the payment history and financial strength of our
operators and have historically established allowance reserves for straight-line
rent adjustments for operators that do not meet our requirements. We
consider factors such as payment history, the operator’s financial condition as
well as current and future anticipated operating trends when evaluating whether
to establish allowance reserves.
Accounts receivable from owned and
operated assets consist of amounts due from Medicare and Medicaid programs,
other government programs, managed care health plans, commercial insurance
companies and individual patients. Amounts recorded include estimated provisions
for loss related to uncollectible accounts and disputed items. For
additional information, see Note 3 – Owned and Operated Assets.
Implementation
of New Accounting Pronouncements:
EITF
03-6-1 Evaluation
In June 2008, the FASB issued FSP EITF
03-6-1, Determining Whether
Instruments Granted in Share-Based Payment Transactions are Participating
Securities. In this FSP, the FASB concluded that all
outstanding unvested share-based payment awards that contain rights to
non-forfeitable dividends or dividend equivalents participate in undistributed
earnings with common shareholders and, accordingly, are considered participating
securities that shall be included in the two-class method of computing basic and
diluted EPS. The FSP does not address awards that contain rights to forfeitable
dividends. We adopted this standard on January 1, 2009, and retrospectively
adjusted basis EPS data for all periods presented to reflect the two-class
method of computing EPS. The provisions of FSP EITF 03-6-1 impact on
earnings per share was less than $0.01 per share for the periods
presented.
FSP
157-4 Evaluation
In April 2009, the FASB issued FSP No.
FAS 157-4, Determining Fair
Value When the Volume and Level of Activity for the Asset or Liability Have
Significantly Decreased and Identifying Transactions That Are Not
Orderly. This FSP provides additional guidance for estimating
fair value in accordance with SFAS No. 157, Fair Value Measurements, when the
volume and level of activity for the asset or liability have significantly
decreased. This FSP also includes guidance on identifying circumstances that
indicate a transaction is not orderly. This FSP emphasizes that even if there
has been a significant decrease in the volume and level of activity for the
asset or liability and regardless of the valuation technique(s) used, the
objective of a fair value measurement remains the same. Fair value is the price
that would be received to sell an asset or paid to transfer a liability in an
orderly transaction (that is, not a forced liquidation or distressed sale)
between market participants at the measurement date under current market
conditions. The FSP is effective for us in the second quarter of 2009 and is not
expected to have a material effect on our financial position or results of
operations.
FSP
107-1 Evaluation
In April 2009, the FASB issued FSP No.
107-1 and Accounting Principles Board (“APB”) Opinion No. 28-1, Interim Disclosures about Fair Value
of Financial Instruments. This FSP amends SFAS No. 107,
Disclosures about Fair Value of Financial Instruments, to require an entity to
provide disclosures about fair value of financial instruments in interim
financial information. This FSP also amends APB Opinion No. 28, Interim
Financial Reporting, to require those disclosures in summarized financial
information at interim reporting periods. Under this FSP, a publicly traded
company shall include disclosures about the fair value of its financial
instruments whenever it issues summarized financial information for interim
reporting periods. In addition, an entity shall disclose in the body or in the
accompanying notes of its summarized financial information for interim reporting
periods and in its financial statements for annual reporting periods the fair
value of all financial instruments for which it is practicable to estimate that
value, whether recognized or not recognized in the statement of financial
position, as required by SFAS No. 107. The FSP is effective for us in the second
quarter of 2009 and will not have a material effect on our financial position or
results of operations.
FAS
157 Evaluation
On January 1, 2008, we adopted FASB
Statement No. 157, Fair Value
Measurements (“FAS No. 157”). This standard defines fair
value, establishes a methodology for measuring fair value and expands the
required disclosure for fair value measurements. FAS No. 157
emphasizes that fair value is a market-based measurement, not an entity-specific
measurement, and states that a fair value measurement should be determined based
on the assumptions that market participants would use in pricing the asset or
liability. This statement applies under other accounting
pronouncements that require or permit fair value measurements, the FASB having
previously concluded in those pronouncements that fair value is the relevant
measurement attribute. Accordingly, this statement does not require
any new fair value measurements. The standard applies prospectively
to new fair value measurements performed after the required effective dates,
which are as follows: (i) on January 1, 2008, the standard applied to our
measurements of the fair values of financial instruments and recurring fair
value measurements of non-financial assets and liabilities; and (ii) on January
1, 2009, the standard applied to all remaining fair value measurements,
including non-recurring measurements of non-financial assets and liabilities
such as measurement of potential impairments of goodwill, other intangible
assets and other long-lived assets. It also will apply to fair value
measurements of non-financial assets acquired and liabilities assumed in
business combinations. We evaluated FAS No. 157 and determined that
the adoption of FAS No. 157 had no impact on our consolidated financial
statements.
FAS
141(R) Evaluation
On December 4, 2007, the FASB issued
Statement No. 141(R), Business
Combinations (“FAS No.
141(R)”). The new standard will significantly change the accounting
for and reporting of business combination transactions. FAS No.
141(R) requires companies to recognize, with certain exception, 100 percent of
the fair value of the assets acquired, liabilities assumed and non-controlling
interest in acquisitions of less than a 100 percent controlling interest when
the acquisition constitutes a change in control; measure acquirer shares issued
as consideration for a business combination at fair value on the date of the
acquisition; recognize contingent consideration arrangements at their
acquisition date fair value, with subsequent change in fair value generally
reflected in earnings; recognition of reacquisition loss and gain contingencies
at their acquisition date fair value; and expense as incurred, acquisition
related transaction costs. FAS No. 141(R) is effective for fiscal
years beginning after December 15, 2008 and early adoption is
prohibited. We adopted the standard on January 1, 2009 and determined
that the adoption of FAS No. 141(R) had no impact on our consolidated financial
statements.
NOTE
2 –PROPERTIES
In the ordinary course of our business
activities, we periodically evaluate investment opportunities and extend credit
to customers. We also regularly engage in lease and loan extensions
and modifications. Additionally, we actively monitor and manage our investment
portfolio with the objectives of improving credit quality and increasing
investment returns. In connection with portfolio management, we may
engage in various collection and foreclosure activities.
If we acquire real estate pursuant to a
foreclosure, lease termination or bankruptcy proceeding and do not immediately
re-lease or sell the properties to new operators, the assets will be included on
the consolidated balance sheet at the lower of cost or estimated fair value (see
Note 3– Owned
and Operated Assets).
Leased
Property
Our leased real estate properties,
represented by 229 skilled nursing facilities (“SNFs”), seven assisted living
facilities (“ALFs”), two rehabilitation hospitals and two independent living
facilities (“ILFs”) at March 31, 2009, are leased under provisions of single
leases and master leases with initial terms typically ranging from 5 to 15
years, plus renewal options. Substantially all of our leases contain
provisions for specified annual increases over the rents of the prior year and
are generally computed in one of three methods depending on specific provisions
of each lease as follows: (i) a specific annual percentage increase over the
prior year’s rent, generally 2.5%; (ii) an increase based on the change in
pre-determined formulas from year to year (i.e., such as increases in the
Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior
years. Under the terms of the leases, the lessee is responsible for
all maintenance, repairs, taxes and insurance on the leased
properties.
Assets
Held for Sale
During the three months ended March 31,
2009, we recorded $0.1 million impairment loss on our held-for-sale facility to
reduce the carrying value to its estimated fair value, less disposal
costs. At March 31, 2009, we had one SNF classified as held-for-sale
with a net book value of approximately $0.1 million.
Mortgage
Notes Receivable
Mortgage notes receivable relate to 15
long-term care facilities. The mortgage notes are secured by first
mortgage liens on the borrowers' underlying real estate and personal
property. The mortgage notes receivable relate to facilities located
in four (4) states, operated by four (4) independent healthcare operating
companies. We monitor compliance with mortgages and when necessary
have initiated collection, foreclosure and other proceedings with respect to
certain outstanding loans. As of March 31, 2009, we had no foreclosed
property, and none of our mortgages were in foreclosure
proceedings. The mortgage properties are cross-collateralized with
the master lease agreement.
Mortgage interest income is recognized
as earned over the terms of the related mortgage notes. Allowances
are provided against earned revenues from mortgage interest when collection of
amounts due becomes questionable or when negotiations for restructurings of
troubled operators lead to lower expectations regarding ultimate
collection. When collection is uncertain, mortgage interest income on
impaired mortgage loans is recognized as received after taking into account
application of security deposits.
NOTE
3 – OWNED AND OPERATED ASSETS
At March 31, 2009, we owned and
operated two facilities with a total of 279 beds that were previously recovered
from a bankrupt operator/tenant.
Since November 2007, affiliates of
Haven Healthcare (“Haven”), one of our operators/lessees/mortgagors, operated
under Chapter 11 bankruptcy protection. Commencing in February 2008,
the assets of the Haven facilities were marketed for sale via an auction process
to be conducted through proceedings established by the bankruptcy
court. The auction process failed to produce a qualified
buyer. As a result, and pursuant to our rights as ordered by the
bankruptcy court, Haven moved the bankruptcy court to authorize us to credit bid
certain of the indebtedness that it owed to us in exchange for taking ownership
of and transitioning certain of its assets to a new entity in which we have a
substantial ownership interest, all of which was approved by the bankruptcy
court on July 4, 2008. Effective as of July 7, 2008, we took
ownership and/or possession of 15 facilities previously operated by Haven and TC
Healthcare, a new entity and an interim operator in which we have a substantial
economic interest, began operating these facilities on our behalf through an
independent contractor.
On August 6, 2008, we entered into a
Master Transaction Agreement (“MTA”) with affiliates of Formation Capital
(“Formation”) whereby Formation agreed (subject to certain closing conditions,
including the receipt of licensure) to lease 14 SNFs and one ALF facility under
a master lease. These facilities were formerly leased to
Haven.
Effective September 1, 2008, we
completed the operational transfer, of 12 SNFs and one ALF to affiliates of
Formation, in accordance with the terms of the MTA. The 13 facilities
are located in Connecticut (5), Rhode Island (4), New Hampshire (3) and
Massachusetts (1). As part of the transaction, Genesis Healthcare
(“Genesis”) has entered into a long-term management agreement with Formation to
oversee the day-to-day operations of each of these facilities. The two remaining
facilities in Vermont, which are currently being operated by TC Healthcare, will
transfer to Formation/Genesis upon the appropriate regulatory approvals expected
sometime in the near future. Our consolidated financial statements
include the financial position and results of operations of TC Healthcare from
July 7, 2008 to March 31, 2009. As of March 31, 2009, our gross
investment in land and buildings for the two properties operated by TC
Healthcare was approximately $14.5 million.
Nursing home revenues and expenses,
included in our consolidated financial statements that relate to such owned and
operated assets are set forth in the tables below.
|
|
Three
Months Ended
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(in
thousands)
|
|
Nursing
home
revenues
|
|
$ |
4,424 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Nursing
home
expenses
|
|
|
5,353 |
|
|
|
— |
|
Loss
from nursing home operations
|
|
$ |
(929 |
) |
|
$ |
— |
|
NOTE
4 – CONCENTRATION OF RISK
As of March 31, 2009, our portfolio of
investments consisted of 256 healthcare facilities, located in 28 states and
operated by 25 third-party operators. Our gross investment in these
facilities, net of impairments and before reserve for uncollectible loans,
totaled approximately $1.5 billion at March 31, 2009, with approximately 99% of
our real estate investments related to long-term care
facilities. This portfolio is made up of 227 SNFs, seven ALFs, two
rehabilitation hospitals, two ILFs, fixed rate mortgages on 15 SNFs, two SNFs
that are owned and operated and one SNF that is currently held for
sale. At March 31, 2009, we also held miscellaneous investments of
approximately $26.9 million, consisting primarily of secured loans to
third-party operators of our facilities.
At March 31, 2009, approximately 24% of
our real estate investments were operated by two public companies: Sun
Healthcare Group, Inc (“Sun”) (14%) and Advocat Inc. (“Advocat”)
(10%). Our largest private company operators (by investment) were
CommuniCare Health Services (“CommuniCare”) (22%) and Signature Holding II, LLC
(10%). No other operator represents more than 9% of our
investments. The three states in which we had our highest
concentration of investments were Ohio (23%), Florida (12%) and Pennsylvania
(10%) at March 31, 2009.
For the three-month period ended March
31, 2009, our revenues from operations totaled $49.2 million, of which
approximately $8.8 million were from CommuniCare (18%), $7.7 million from Sun
(16%) and $5.1 million from Advocat (10%). Our owned and operated
assets generated $4.4 million (9%) of revenue in March 31, 2009. No
other operator generated more than 9% of our revenues from operations for the
three-month period ended March 31, 2009.
Sun and Advocat are subject to the reporting
requirements of the Securities Exchange Commission (“SEC”) and are required to
file with the SEC annual reports containing audited financial information and
quarterly reports containing unaudited interim financial
information. Sun and Advocat’s filings with the SEC can be found at
the SEC’s website at www.sec.gov. We are providing this data for
information purposes only, and you are encouraged to obtain Sun’s and Advocat’s
publicly available filings from the SEC.
NOTE
5 –DIVIDENDS
Common
Dividends
On April 16, 2009, the Board of
Directors declared a common stock dividend of $0.30 per share to be paid May 15,
2009 to common stockholders of record on April 30, 2009.
On January 15, 2009, the Board of
Directors declared a common stock dividend of $0.30 per share that was paid on
February 17, 2009 to common stockholders of record on January 30,
2009.
Series
D Preferred Dividends
On April 16, 2009, the Board of
Directors declared regular quarterly dividends for the 8.375% Series D
cumulative redeemable preferred stock (the “Series D Preferred Stock”) to
preferred stockholders of record on April 30, 2009. The stockholders
of record of the Series D Preferred Stock on April 30, 2009 will be paid
dividends in the amount of $0.52344 per preferred share on May 15,
2009. The liquidation preference for our Series D Preferred Stock is
$25.00 per share. Regular quarterly preferred dividends for the
Series D Preferred Stock represent dividends for the period February 1, 2009
through April 30, 2009.
On January 15, 2009, the Board of
Directors declared regular quarterly dividends of approximately $0.52344 per
preferred share on the Series D Preferred Stock that were paid February 17, 2009
to preferred stockholders of record on January 30, 2009.
NOTE
6 – TAXES
So long as we qualify as a real estate
investment trust (“REIT”) under the Internal Revenue Code (the “Code”), we
generally will not be subject to federal income taxes on the REIT taxable income
that we distribute to stockholders, subject to certain exceptions. On
a quarterly and annual basis, we test our compliance within the REIT taxation
rules to ensure that we were in compliance with the rules.
Subject to the limitation under the
REIT asset test rules, we are permitted to own up to 100% of the stock of one or
more taxable REIT subsidiary (“TRSs”). Currently, we have one TRS
that is taxable as a corporation and that pays federal, state and local income
tax on its net income at the applicable corporate rates. The TRS had
a net operating loss carry-forward as of March 31, 2009 of $1.1
million. The loss carry-forward was fully reserved with a valuation
allowance due to uncertainties regarding realization.
NOTE
7 – STOCK-BASED COMPENSATION
The following is a summary of our stock
based compensation expense for the three- month period ended March 31, 2009 and
2008, respectively:
|
|
Three
Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(in
thousands)
|
|
|
|
|
|
|
|
|
Restricted
stock expense
|
|
$ |
480 |
|
|
$ |
526 |
|
2007
Stock Awards
In May 2007, we granted 286,908 shares
of restricted stock and 247,992 performance restricted stock units (“PRSU”) to
five executive officers under the 2004 Plan Stock Incentive Plan (the “2004
Plan”).
Restricted
Stock Award
The
restricted stock award vests one-seventh on December 31, 2007 and two-sevenths
on December 31, 2008, December 31, 2009, and December 31, 2010, respectively,
subject to continued employment on the vesting date (as defined in the
agreements filed with the SEC on May 8, 2007). As of March 31, 2009,
122,961 shares of restricted stock have vested under the restricted stock
award.
Performance
Restricted Stock Units
We awarded two types of PRSUs (annual
and cliff vesting awards) to the five executives. One half of the
PRSU awards vest annually in equal increments on December 31, 2008, December 31,
2009, and December 31, 2010, respectively. The other half of the PRSU
awards cliff vest on December 31, 2010. Vesting on both types of
awards requires achievement of total shareholder return (as defined in the
agreements filed with the SEC on May 8, 2007).
The following table summarizes our
total unrecognized compensation cost associated with the restricted stock awards
and PRSUs awarded in May 2007 as of March 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares/
Units
|
|
|
Grant
Date Fair Value Per Unit/ Share
|
|
|
Total
Compensation Cost
|
|
|
Weighted
Average Period of Expense Recognition (in months)
|
|
|
Unrecognized
Compensation Cost
|
|
|
|
(in
thousands, except share and per share amounts)
|
|
Restricted
stock
|
|
|
286,908 |
|
|
$ |
17.06 |
|
|
$ |
4,895 |
|
|
|
44 |
|
|
$ |
2,336 |
|
2008
Annual performance restricted stock units
|
|
|
41,332 |
|
|
|
8.78 |
|
|
|
363 |
|
|
|
20 |
|
|
|
- |
|
2009
Annual performance restricted stock units
|
|
|
41,332 |
|
|
|
8.25 |
|
|
|
341 |
|
|
|
32 |
|
|
|
96 |
|
2010
Annual performance restricted stock units
|
|
|
41,332 |
|
|
|
8.14 |
|
|
|
336 |
|
|
|
44 |
|
|
|
161 |
|
3
year cliff vest performance restricted stock units
|
|
|
123,996 |
|
|
|
6.17 |
|
|
|
765 |
|
|
|
44 |
|
|
|
365 |
|
Total
|
|
|
534,900 |
|
|
|
|
|
|
$ |
6,700 |
|
|
|
|
|
|
$ |
2,958 |
|
As of March 31, 2009, we had 23,664
stock options and 20,401 shares of restricted stock outstanding to
directors. The stock options were fully vested as of January 1, 2007
and the restricted shares are scheduled to vest over the next three
years. As of March 31, 2009, the unrecognized compensation cost
associated with the directors is $0.3 million.
NOTE
8 – FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS
Bank
Credit Agreements
At March 31, 2009, we had $55.0 million
outstanding under our $255 million revolving senior secured credit facility (the
“Credit Facility”) and no letters of credit outstanding, leaving availability of
$200.0 million. The $55.0 million of outstanding borrowings had a
blended interest rate of 1.3% at March 31, 2009. The Credit Facility
matures in March 2010.
Our long-term borrowings require us to
meet certain property level financial covenants and corporate financial
covenants, including prescribed leverage, fixed charge coverage, minimum net
worth, limitations on additional indebtedness and limitations on dividend
payouts. As of March 31, 2009, we were in compliance with all
property level and corporate financial and non-financial covenants.
Dividend
Reinvestment and Common Stock Purchase Plan
We have a Dividend Reinvestment and
Common Stock Purchase Plan (the “DRSPP”) that allows for the reinvestment of
dividends and the optional purchase of our common stock. For the
three- month period ended March 31, 2009, we issued 14,633 shares of common
stock for approximately $0.2 million in net proceeds.
Effective
as of May 15, 2009, we are reinstating the optional cash purchase component of
our DRSPP, which we had temporarily suspended in October 2008.
NOTE
9 – LITIGATION
We are subject to various legal
proceedings, claims and other actions arising out of the normal course of
business. While any legal proceeding or claim has an element of uncertainty,
management believes that the outcome of each lawsuit, claim or legal proceeding
that is pending or threatened, or all of them combined, will not have a material
adverse effect on our consolidated financial position or results of
operations.
In 1999, we filed suit against a former
tenant seeking damages based on claims of breach of contract. The
defendants denied the allegations made in the lawsuit. In June 2008,
we were awarded damages in a jury trial. The case was then settled
prior to appeal. In settlement of our claim against the defendants,
we agreed in January 2009 to accept a lump sum cash payment of $6.8
million. The cash proceeds were offset by related expenses incurred
of $2.3 million, resulting in a net gain of $4.5 million paid in January
2009. We recorded this gain during the first quarter of
2009.
NOTE
10 – DISCONTINUED OPERATIONS
Statement of Financial Accounting
Standards (“SFAS”) No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets, requires the presentation of the net
operating results of facilities classified as discontinued operations for all
periods presented.
The following table summarizes the
results of discontinued operations for facilities sold or held-for-sale during
the three months ended March 31, 2009 and 2008, respectively.
|
|
Three
Months Ended
|
|
|
|
March
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(in
thousands)
|
|
Revenues
|
|
|
|
|
|
|
Rental income
|
|
$ |
— |
|
|
$ |
15 |
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Income
before gain on sale of assets
|
|
|
— |
|
|
|
15 |
|
Gain
on assets sold – net
|
|
|
— |
|
|
|
431 |
|
Discontinued
operations
|
|
$ |
— |
|
|
$ |
446 |
|
During the first quarter of 2009, no
revenue or expense generated from discontinued operations.
During the first quarter of 2008,
discontinued operations includes revenue of $15 thousand for one SNF located in
California that was sold during the quarter for a gain of $0.4
million.
NOTE
11 – EARNINGS PER SHARE
We calculate basic and diluted earnings
per common share (“EPS”) in accordance with FAS No. 128, Earnings Per
Share. The computation of basic EPS is computed by dividing
net income available to common stockholders by the weighted-average number of
shares of common stock outstanding during the relevant
period. Diluted EPS is computed using the treasury stock method,
which is net income divided by the total weighted-average number of common
outstanding shares plus the effect of dilutive common equivalent shares during
the respective period. Dilutive common shares reflect the assumed
issuance of additional common shares pursuant to certain of our share-based
compensation plans, including stock options, restricted stock and performance
restricted stock units.
The following tables set forth the
computation of basic and diluted earnings per share:
|
|
Three
Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(in
thousands, except per share amounts)
|
|
Numerator:
|
|
|
|
|
|
|
Income from continuing
operations
|
|
$ |
24,912 |
|
|
$ |
16,788 |
|
Preferred stock
dividends
|
|
|
(2,271 |
) |
|
|
(2,481 |
) |
Numerator for income available
to common shareholders from continuing operations - basic and
diluted
|
|
|
22,641 |
|
|
|
14,307 |
|
Discontinued
operations
|
|
|
— |
|
|
|
446 |
|
Numerator for net income
available to common per share - basic and diluted
|
|
$ |
22,641 |
|
|
$ |
14,753 |
|
Denominator:
|
|
|
|
|
|
|
|
|
Denominator for basic earnings
per share
|
|
|
82,396 |
|
|
|
68,680 |
|
Effect of dilutive
securities:
|
|
|
|
|
|
|
|
|
Restricted
stock
|
|
|
69 |
|
|
|
56 |
|
Stock option incremental
shares
|
|
|
10 |
|
|
|
11 |
|
Deferred stock
|
|
|
3 |
|
|
|
— |
|
Denominator for diluted
earnings per share
|
|
|
82,478 |
|
|
|
68,747 |
|
|
|
|
|
|
|
|
|
|
Earnings
per share - basic:
|
|
|
|
|
|
|
|
|
Income available to common
shareholders from continuing operations
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Discontinued
operations
|
|
|
— |
|
|
|
— |
|
Net income -
basic
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Earnings
per share - diluted:
|
|
|
|
|
|
|
|
|
Income available to common
shareholders from continuing operations
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Discontinued
operations
|
|
|
— |
|
|
|
— |
|
Net income -
diluted
|
|
$ |
0.27 |
|
|
$ |
0.21 |
|
Forward-looking
Statements, Reimbursement Issues and Other Factors Affecting Future
Results
The following discussion should be read
in conjunction with the financial statements and notes thereto appearing
elsewhere in this document. This document contains forward-looking
statements within the meaning of the federal securities laws, including
statements regarding potential financings and potential future changes in
reimbursement. These statements relate to our expectations, beliefs,
intentions, plans, objectives, goals, strategies, future events, performance and
underlying assumptions and other statements other than statements of historical
facts. In some cases, you can identify forward-looking statements by
the use of forward-looking terminology including, but not limited to, terms such
as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or
comparable terms or the negative thereof. These statements are based
on information available on the date of this filing and only speak as to the
date hereof and no obligation to update such forward-looking statements should
be assumed. Our actual results may differ materially from those
reflected in the forward-looking statements contained herein as a result of a
variety of factors, including, among other things:
(i)
|
those
items discussed under “Risk Factors” in Item 1A to our annual report on
Form 10-K for the year ended December 31, 2008 and in Part II, Item 1A of
this report;
|
(ii)
|
uncertainties
relating to the business operations of the operators of our assets,
including those relating to reimbursement by third-party payors,
regulatory matters and occupancy
levels;
|
(iii)
|
the
ability of any operators in bankruptcy to reject unexpired lease
obligations, modify the terms of our mortgages and impede our ability to
collect unpaid rent or interest during the process of a bankruptcy
proceeding and retain security deposits for the debtors’
obligations;
|
(iv)
|
our
ability to sell closed or foreclosed assets on a timely basis and on terms
that allow us to realize the carrying value of these
assets;
|
(v)
|
our
ability to negotiate appropriate modifications to the terms of our credit
facility;
|
(vi)
|
our
ability to manage, re-lease or sell any owned and operated
facilities;
|
(vii)
|
the
availability and cost of capital;
|
(viii)
|
our
ability to maintain our credit
ratings;
|
(ix)
|
competition
in the financing of healthcare
facilities;
|
(x)
|
regulatory
and other changes in the healthcare
sector;
|
(xi)
|
the
effect of economic and market conditions generally and, particularly, in
the healthcare industry;
|
(xii)
|
changes
in the financial position of our
operators;
|
(xiii)
|
changes
in interest rates;
|
(xiv)
|
the
amount and yield of any additional
investments;
|
(xv)
|
changes
in tax laws and regulations affecting real estate investment
trusts;
|
(xvi)
|
our
ability to maintain our status as a real estate investment
trust;
|
(xvii)
|
changes
in our credit ratings and the ratings of our debt and preferred
securities;
|
(xviii)
|
the
potential impact of a general economic slowdown on governmental budgets
and healthcare reimbursement expenditures;
and
|
(xix)
|
the
effect of the recent financial crisis and severe tightening in the global
credit markets.
|
Overview
We have one reportable segment
consisting of investments in healthcare related real estate
properties. Our core business is to provide financing and capital to
the long-term healthcare industry with a particular focus on skilled nursing
facilities located in the United States. Our core portfolio consists
of long-term leases and mortgage agreements. All of our leases are
“triple-net” leases, which require the tenants to pay all property-related
expenses. Our mortgage revenue derives from fixed-rate mortgage
loans, which are secured by first mortgage liens on the underlying real estate
and personal property of the mortgagor. In July 2008, we assumed
operating responsibilities for 15 of our facilities due to the bankruptcy of one
of our operator/tenants. In September 2008, we entered into an
agreement to lease these facilities to a new operator/tenant. The new
operator/tenant assumed operating responsibility for 13 of the 15 facilities
effective September 1, 2008. We continue to be responsible for the
two remaining facilities as of March 31, 2009 that are in the process of being
transitioned to the new tenant/operator pending approval by state
regulators.
Our
consolidated financial statements include the accounts of Omega, all direct and
indirect wholly owned subsidiaries; as well as TC Healthcare I, LLC. (“TC
Healthcare”), a new entity and interim operator created to operate the 15
facilities we assumed as a result of the bankruptcy of one our
tenant/operators. We consolidate the financial results of TC
Healthcare into our financial statements based on the application of the
applicable consolidation accounting literature. We include the
operating results and assets and liabilities of these facilities for the period
of time that TC Healthcare was responsible for the operations of the
facilities. Thirteen of these facilities were transitioned from TC
Healthcare to a new tenant/operator on September 1, 2008, however, TC Healthcare
continues to be responsible for two facilities as of March 31, 2009 that are in
the process of being transitioned to the new operator/tenant pending approval by
state regulators. The operating revenues and expenses and related
operating assets and liabilities of the owned and operated facilities are shown
on a gross basis in our Consolidated Statements of Income and Consolidated
Balance Sheets, respectively. All inter-company accounts and
transactions have been eliminated in consolidation of the financial
statements.
Our
portfolio of investments at March 31, 2009, consisted of 256 healthcare
facilities, located in 28 states and operated by 25 third-party
operators. Our gross investment in these facilities totaled
approximately $1.5 billion at March 31, 2009, with 99% of our real estate
investments related to long-term healthcare facilities. This
portfolio is made up of (i) 227 skilled nursing facilities (“SNFs’), (ii) seven
assisted living facilities (“ALFs”), (iii) two rehabilitation hospitals owned
and leased to third parties, (iii) two independent living facilities (“ILFs”),
(iv) fixed rate mortgages on 15 skilled nursing facilities(“SNFs”), (v) two
skilled nursing facilities (“SNFs”) that are owned and operated and (vi) one
skilled nursing facility (“SNF”) that is currently held for sale. At
March 31, 2009, we also held other investments of approximately $26.9 million,
consisting primarily of secured loans to third-party operators of our
facilities.
Taxation
We have elected to be taxed as a REIT,
under Sections 856 through 860 of the internal revenue code (the “Code”),
beginning with our taxable year ended December 31, 1992. We believe
that we have been organized and operated in such a manner as to qualify for
taxation as a REIT. We intend to continue to operate in a manner that will
maintain our qualification as a REIT, but no assurance can be given that we have
operated or will be able to continue to operate in a manner so as to qualify or
remain qualified as a REIT. Under the Code, we generally are not
subject to federal income tax on taxable income distributed to stockholders if
certain distribution, income, asset and stockholder tests are met, including a
requirement that we must generally distribute at least 90% of our annual taxable
income, excluding any net capital gain, to stockholders. If we fail
to qualify as a REIT in any taxable year, we may be subject to federal income
taxes on our taxable income for that year and for the four years following the
year during which qualification is lost, unless the Internal Revenue Service
grants us relief under certain statutory provisions. Such an event could
materially adversely affect our net income and net cash available for
distribution to our stockholders. For further information, see
“Taxation” in Item 1 of our annual report on Form 10-K for the year ended
December 31, 2008
Recent
Developments Regarding Government Regulation and Reimbursement
Reimbursement. The
recent downturn in the U.S. economy and other factors could result in
significant cost-cutting at both the federal and state levels, resulting in a
reduction of reimbursement rates and levels to our operators under both the
Medicare and Medicaid programs. We currently believe that our
operator coverage ratios are adequate and that our operators can absorb moderate
reimbursement rate reductions under Medicaid and Medicare and still meet their
obligations to us. However, significant limits on the scope of services
reimbursed and on reimbursement rates and fees could have a material adverse
effect on an operator’s results of operations and financial condition, which
could adversely affect the operator’s ability to meet its obligations to
us.
Medicaid. Current
market and economic conditions will likely have a significant impact on state
budgets and health care spending. The states with the most significant projected
budget deficits in which the Company owns facilities are Alabama, Arizona,
California, Florida, New Hampshire and Rhode Island. These
deficits, exacerbated by the potential for increased enrollment in Medicaid due
to rising unemployment levels and declining family incomes, could cause states
to reduce state expenditures under their respective state Medicaid programs by
lowering reimbursement rates. Since the profit margins on Medicaid
patients are generally relatively low, substantial reductions in Medicaid
reimbursement could adversely affect our operators’ results of operations and
financial condition, which in turn could negatively impact us.
The
American Recovery and Reinvestment Act of 2009 (ARRA), which was signed into law
on February 17, 2009, provides for enhanced federal Medicaid matching rates that
may provide some relief to states. Because states have discretion
with respect to their Medicaid programs, some states may address budget
shortfalls outside of Medicaid by reallocating state funds that otherwise would
have been spent on Medicaid expenditures. As a result, the impact of
the ARRA Medicaid funding on our operators will depend on how states choose to
use the funding.
In 2007
and early 2008, the Center for Medicare & Medicaid Services (“CMS”) issued a
number of Medicaid rules that could reduce funding available under state
Medicaid programs to reimburse long-term care providers. On June 30,
2008, the Supplemental Appropriations Act of 2008 (H.R. 2642) was signed into
law, delaying the implementation of a number of these rules until April 1,
2009. The Medicaid rules that were delayed until April 1, 2009 by the
legislation address the following issues: intergovernmental
transfers; coverage of rehabilitation services for people with disabilities;
outreach and enrollment funded by Medicaid in schools; specialized
transportation to schools for children covered by Medicaid; graduate medical
education payments; targeted case management services and some provisions
relating to state provider tax limits. If some or all of these
delayed regulations go into effect in the future, the additional financial
burden placed on states could result in the operators of our properties
experiencing significant reductions in Medicaid reimbursement
levels.
However,
the Supplemental Appropriations Act of 2008 did not delay other recent Medicaid
rules that could negatively impact Medicaid reimbursement levels for long-term
care providers. Congress permitted certain Medicaid rules to become
effective, such as rules relating to outpatient hospital services and some
provisions relating to state provider tax limits. For example, on
April 22, 2008, a federal Medicaid rule that reduced the maximum allowable
health care-related taxes that states can impose on providers from 6 percent to
5.5 percent became effective. This rule could result in lower taxes
for providers, but could also result in less overall funding for state Medicaid
programs by limiting the ability of states to fund the non-federal share of the
Medicaid program. As a result, the operators of our properties could
potentially experience reductions in Medicaid funding, which could adversely
impact their ability to meet their obligations to us.
Medicare. On
May 1, 2009, CMS issued a proposed rule on Medicare’s prospective payment system
for skilled nursing facilities for fiscal year 2010. CMS estimates
that the proposed rule would decrease aggregate Medicare payments to skilled
nursing facilities during fiscal year 2010 by approximately $390 million, or 1.2
percent. The fiscal year 2010 market basket adjustment of 2.1
percent, or $660 million, would offset a $1.05 billion adjustment resulting from
the recalibration of the case-mix indexes, resulting in a net decrease in
payments of $390 million. If the proposed rule is finalized, our
operators may receive reduced Medicare payments, which could have an adverse
effect on their ability to satisfy their financial obligations.
On August
8, 2008, CMS published a final rule on Medicare’s prospective payment system for
skilled nursing facilities for fiscal year 2009, which CMS estimates will
increase aggregate Medicare payments to skilled nursing facilities during fiscal
year 2009 by $780 million. CMS notes that the increase in payments is
due to an increase in the market basket adjustment factor of 3.4
percent.
The
Medicare Improvements for Patients and Providers Act of 2008 (“MIPPA”) became
law on July 15, 2008 and made a variety of changes to Medicare, some of which
may affect skilled nursing facilities. For instance, MIPPA extended
the therapy caps exceptions process through December 31, 2009. The
therapy caps limit the physical therapy, speech-language therapy and
occupational therapy services that a Medicare beneficiary can receive during a
calendar year. These caps do not apply to therapy services covered
under Medicare Part A in a skilled nursing facility, although the caps apply in
most other instances involving patients in skilled nursing facilities or
long-term care facilities who receive therapy services covered under Medicare
Part B. Congress implemented a temporary therapy cap exceptions
process, which permits medically necessary therapy services to exceed the
payment limits. MIPPA retroactively extended the therapy caps
exceptions process through December 31, 2009. Expiration of the
therapy caps exceptions process in the future could have a material adverse
effect on our operators’ financial condition and operations, which could
adversely impact their ability to meet their obligations to us.
Quality of Care
Initiatives. CMS has implemented a number of initiatives
focused on the quality of care provided by nursing homes that could affect our
operators. For instance, in February 2008, CMS made publicly
available on its website the names of all 136 nursing homes targeted in its
Special Focus Facility program for underperforming nursing homes. CMS
plans to update the list regularly. As another example, in December
2008, CMS released quality ratings for all of the nursing homes that participate
in Medicare or Medicaid. Facility rankings, ranging from five stars
(“much above average”) to one star (“much below average”) will be updated on a
monthly basis. In the event any of our operators do not maintain the
same or superior levels of quality care as their competitors, patients could
choose alternate facilities, which could adversely impact our operators’
revenues. In addition, the reporting of such information could lead
to future reimbursement policies that reward or penalize facilities on the basis
of the reported quality of care parameters.
The
Office of Inspector General (“OIG”) of the Department of Health and Human
Services also has carried out a number of projects focused on the quality of
care provided by nursing homes. For example, in September 2008,
the OIG released a report based on an analysis of data from CMS’ Online Survey
and Certification Reporting System (“OSCAR”), which contains the results of all
state nursing home surveys. The report notes that over 91 percent of
nursing homes surveyed were cited for deficiencies and complaints between 2005
and 2007. The most common deficiencies cited involved quality of
care, resident assessments and quality of life. A greater percentage
of for-profit nursing homes were cited than not-for-profit and government
nursing homes. In addition, the OIG’s Work Plan for fiscal year 2009,
which describes projects that the OIG plans to address during the fiscal year,
includes a number of projects related to nursing homes.
Critical
Accounting Policies and Estimates
Our financial statements are prepared
in accordance with generally accepted accounting principles in the United States
of America (“GAAP”) and a summary of our significant accounting policies is
included in Note 2 – Summary of Significant Accounting Policies to our Annual
Report on Form 10-K for the year ended December 31, 2008. Our
preparation of the financial statements requires us to make estimates and
assumptions about future events that affect the amounts reported in our
financial statements and accompanying footnotes. Future events and
their effects cannot be determined with absolute
certainty. Therefore, the determination of estimates requires the
exercise of judgment. Actual results inevitably will differ from
those estimates, and such difference may be material to the consolidated
financial statements. We have described our most critical accounting
policies in our 2008 Annual Report on Form 10-K in Item 7, Management’s
Discussion and Analysis of Financial Condition and Results of
Operations.
Recent
Accounting Pronouncements:
EITF
03-6-1 Evaluation
In June 2008, the FASB issued FSP EITF
03-6-1, Determining Whether
Instruments Granted in Share-Based Payment Transactions are Participating
Securities. In this FSP, the FASB concluded that all outstanding unvested
share-based payment awards that contain rights to non-forfeitable dividends or
dividend equivalents participate in undistributed earnings with common
shareholders and, accordingly, are considered participating securities that
shall be included in the two-class method of computing basic and diluted EPS.
The FSP does not address awards that contain rights to forfeitable dividends. We
adopted this standard on January 1, 2009, and retrospectively adjusted basis EPS
data for all periods presented to reflect the two-class method of computing
EPS. The provisions of FSP EITF 03-6-1 impact on earnings per share
was less than $0.01 per share for the periods presented.
FSP
157-4 Evaluation
In April 2009, the FASB issued FSP No.
FAS 157-4, Determining Fair
Value When the Volume and Level of Activity for the Asset or Liability Have
Significantly Decreased and Identifying Transactions That Are Not
Orderly. This FSP provides additional guidance for estimating fair value
in accordance with SFAS No. 157, Fair Value Measurements, when the volume and
level of activity for the asset or liability have significantly decreased. This
FSP also includes guidance on identifying circumstances that indicate a
transaction is not orderly. This FSP emphasizes that even if there has been a
significant decrease in the volume and level of activity for the asset or
liability and regardless of the valuation technique(s) used, the objective of a
fair value measurement remains the same. Fair value is the price that would be
received to sell an asset or paid to transfer a liability in an orderly
transaction (that is, not a forced liquidation or distressed sale) between
market participants at the measurement date under current market conditions. The
FSP is effective for us in the second quarter of 2009 and is not expected to
have a material effect on our financial position or results of
operations.
FSP
107-1 Evaluation
In April 2009, the FASB issued FSP No.
107-1 and Accounting Principles Board (“APB”) Opinion No. 28-1, Interim Disclosures about Fair Value
of Financial Instruments. This FSP amends SFAS No. 107, Disclosures about
Fair Value of Financial Instruments, to require an entity to provide disclosures
about fair value of financial instruments in interim financial information. This
FSP also amends APB Opinion No. 28, Interim Financial Reporting, to require
those disclosures in summarized financial information at interim reporting
periods. Under this FSP, a publicly traded company shall include disclosures
about the fair value of its financial instruments whenever it issues summarized
financial information for interim reporting periods. In addition, an entity
shall disclose in the body or in the accompanying notes of its summarized
financial information for interim reporting periods and in its financial
statements for annual reporting periods the fair value of all financial
instruments for which it is practicable to estimate that value, whether
recognized or not recognized in the statement of financial position, as required
by SFAS No. 107. The FSP is effective for us in the second quarter of 2009 and
will not have a material effect on our financial position or results of
operations.
FAS
157 Evaluation
On January 1, 2008, we adopted
Financial Accounting Standards Board, (“FASB”), Statement No. 157, Fair Value Measurements (“FAS
No. 157”). This standard defines fair value, establishes a
methodology for measuring fair value and expands the required disclosure for
fair value measurements. FAS No. 157 emphasizes that fair value is a
market-based measurement, not an entity-specific measurement, and states that a
fair value measurement should be determined based on the assumptions that market
participants would use in pricing the asset or liability. This
statement applies under other accounting pronouncements that require or permit
fair value measurements, the FASB having previously concluded in those
pronouncements that fair value is the relevant measurement
attribute. Accordingly, this statement does not require any new fair
value measurements. The standard applies prospectively to new fair
value measurements performed after the required effective dates, which are as
follows: (i) on January 1, 2008, the standard applied to our measurements of the
fair values of financial instruments and recurring fair value measurements of
non-financial assets and liabilities; and (ii) on January 1, 2009, the standard
will apply to all remaining fair value measurements, including non-recurring
measurements of non-financial assets and liabilities such as measurement of
potential impairments of goodwill, other intangible assets and other long-lived
assets. It also will apply to fair value measurements of non-financial assets
acquired and liabilities assumed in business combinations. We evaluated FAS No.
157 and determined that the adoption of FAS No. 157 had no impact on our
consolidated financial statements.
FAS
141(R) Evaluation
On December 4, 2007, the Financial
Accounting Standards Board issued Statement No. 141(R), Business Combinations (“FAS
No. 141(R)”). The new standard will significantly change the
accounting for and reporting of business combination
transactions. FAS No. 141(R) requires companies to recognize, with
certain exception, 100 percent of the fair value of the assets acquired,
liabilities assumed and non-controlling interest in acquisitions of less than a
100 percent controlling interest when the acquisition constitutes a change in
control; measure acquirer shares issued as consideration for a business
combination at fair value on the date of the acquisition; recognize contingent
consideration arrangements at their acquisition date fair value, with subsequent
change in fair value generally reflected in earnings; recognition of
reacquisition loss and gain contingencies at their acquisition date fair value;
and expense as incurred, acquisition related transaction costs. FAS
No. 141(R) is effective for fiscal years beginning after December 15, 2008 and
early adoption was prohibited. We adopted the standard on January 1,
2009 and determined that the adoption of FAS No. 141(R) had no impact on our
consolidated financial statements.
Results
of Operations
The following is our discussion of the
consolidated results of operations, financial position and liquidity and capital
resources, which should be read in conjunction with our unaudited consolidated
financial statements and accompanying notes.
Three
Months Ended March 31, 2009 and 2008
Operating
Revenues
Our operating revenues for the three
months ended March 31, 2009 totaled $49.2 million, an increase of $8.3 million
over the same period in 2008. The $8.3 million increase relates
primarily to: (i) $4.4 million nursing home revenues of owned and operated
assets in 2009 compared to 2008, as a result of the July 2008 assumption of
operating responsibility for the facilities formerly operated by Haven, ii)
additional rental income as a result of the acquisitions since March 2008, and
(iii) additional mortgage income associated with the mortgage financing of eight
new facilities in April 2008. Miscellaneous revenue decreased by $1.2
million in 2009. In 2008, we received past due rent from a former
operator of $0.7 million and late fees of approximately $0.5
million.
Operating
Expenses
Operating expenses for the three
months ended March 31, 2009 totaled $19.5 million, an increase of approximately
$5.5 million over the same period in 2008. The increase was primarily
due to $5.4 million nursing home expenses in owned and operated assets in 2009
compared to 2008, as a result of the July 2008 assumption of operating
responsibility for the facilities formerly operated by Haven; and an increase in
depreciation expense of $1.5 million due to acquisitions since March 2008;
partially offset by a decrease in provision for impairment of $1.4
million.
Other
Income (Expense)
For the three months ended March 31,
2009, total other expenses were $4.7 million, as compared to $10.1 million for
the same period in 2008, a decrease of $5.4 million. The decrease was
due to lower average LIBOR interest rates on our outstanding borrowings and $4.5
million associated with cash received for a legal settlement in the first
quarter of 2009.
Income
from Continuing Operations
Income from continuing operations for
the three months ended March 31, 2009 was $24.9 million compared to $16.8
million for the same period in 2008. The increase in income from
continuing operations is the result of the factors described above.
Discontinued
Operations
Discontinued operations generally
relate to properties we disposed of or plan to dispose of and have no continuing
involvement or cash flows with the operator. These assets included in
assets held for sale – net in our balance sheet prior to their
sale/disposal.
For the three months ended March 31,
2009, no revenue or
expense generated from discontinued operations. For the three months ended March 31,
2008, discontinued
operations includes revenue of $15 thousand for one SNF located in California
that was sold during the quarter, generating a gain of $0.4
million.
Funds
From Operations
Our funds
from operations available to common stockholders (“FFO”), for the three months
ended March 31, 2009, was $33.6 million, compared to $23.7 million, for the same
period in 2008.
We
calculate and report FFO in accordance with the definition and interpretive
guidelines issued by the National Association of Real Estate Investment Trusts
(“NAREIT”), and consequently, FFO is defined as net income available to common
stockholders, adjusted for the effects of asset dispositions and certain
non-cash items, primarily depreciation and amortization. We believe
that FFO is an important supplemental measure of our operating
performance. Because the historical cost accounting convention used
for real estate assets requires depreciation (except on land), such accounting
presentation implies that the value of real estate assets diminishes predictably
over time, while real estate values instead have historically risen or fallen
with market conditions. The term FFO was designed by the real estate
industry to address this issue. FFO herein is not necessarily
comparable to FFO of other REITs that do not use the same definition or
implementation guidelines or interpret the standards differently from
us.
We use
FFO as one of several criteria to measure operating performance of our
business. We further believe that by excluding the effect of
depreciation, amortization and gains or losses from sales of real estate, all of
which are based on historical costs and which may be of limited relevance in
evaluating current performance, FFO can facilitate comparisons of operating
performance between periods. We offer this measure to assist the
users of our financial statements in analyzing our financial performance;
however, this is not a measure of financial performance under GAAP and should
not be considered a measure of liquidity, an alternative to net income or an
indicator of any other performance measure determined in accordance with
GAAP. Investors and potential investors in our securities should not
rely on this measure as a substitute for any GAAP measure, including net
income.
The following table reconciles FFO to
net income available to common stockholders, as determined under GAAP, for the
three- months ended March 31, 2009 and 2008:
|
|
Three
Months Ended
|
|
|
|
March
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(in
thousands)
|
|
|
|
|
|
|
|
|
Net
income available to common stockholders
|
|
$ |
22,641 |
|
|
$ |
14,753 |
|
Deduct gain from real estate
dispositions
|
|
|
— |
|
|
|
(477 |
) |
|
|
|
22,641 |
|
|
|
14,276 |
|
Elimination
of non-cash items included in net income:
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
10,931 |
|
|
|
9,396 |
|
Funds
from operations available to common stockholders
|
|
$ |
33,572 |
|
|
$ |
23,672 |
|
|
Portfolio
and Recent Developments
|
There was no re-leasing, restructuring
or new investment transactions that occurred during the three months ended March
31, 2009.
Held
for Sale
During the three months ended March 31,
2009, we recorded $0.1 million impairment loss on our held-for-sale facility to
reduce the carrying value to its estimated fair value, less disposal
costs. At March 31, 2009, we had one SNF classified as held-for-sale
with a net book value of approximately $0.1 million.
Liquidity
and Capital Resources
At March 31, 2009, we had total assets
of $1.4 billion, stockholders’ equity of $786.5 million and debt of $539.7
million, which represents approximately 40.7% of our total
capitalization.
The
following table shows the amounts due in connection with the contractual
obligations described below as of March 31, 2009.
|
|
Payments due by period
|
|
|
|
Total
|
|
|
Less
than
1
year
|
|
|
1-3
years
|
|
|
3-5
years
|
|
|
More
than
5
years
|
|
|
|
(In
thousands)
|
|
Debt
(1)
|
|
$ |
540,000 |
|
|
$ |
55,000 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
485,000 |
|
Operating
lease obligations(2)
|
|
|
3,193 |
|
|
|
258 |
|
|
|
586 |
|
|
|
618 |
|
|
|
1,731 |
|
Total
|
|
$ |
543,193 |
|
|
$ |
55,258 |
|
|
$ |
586 |
|
|
$ |
618 |
|
|
$ |
486,731 |
|
(1)
|
The
$540.0 million includes $310 million aggregate principal amount of 7%
Senior Notes due April 2014, $175 million aggregate principal amount of 7%
Senior Notes due January 2016, and $55.0 million in borrowings under the
$255 million revolving senior secured credit facility that matures in
March 2010.
|
(2)
|
Relates
primarily to the lease at the corporate
headquarters.
|
Financing
Activities and Borrowing Arrangements
Bank
Credit Agreements
At March 31, 2009, we had $55.0 million
outstanding under our $255 million revolving senior secured credit facility (the
“Credit Facility”) and no letters of credit outstanding, leaving availability of
$200.0 million. The $55.0 million of outstanding borrowings had a
blended interest rate of 1.3% at March 31, 2009. The Credit Facility
matures in March 2010.
Our long-term borrowings require us to
meet certain property level financial covenants and corporate financial
covenants, including prescribed leverage, fixed charge coverage, minimum net
worth, limitations on additional indebtedness and limitations on dividend
payouts. As of March 31, 2009, we were in compliance with all
property level and corporate financial and non-financial
covenants.
We are
currently evaluating opportunities to replace or refinance our existing Credit
Facility scheduled to mature in March 2010. Based on our discussions
with potential lenders, we currently expect to be able to replace or refinance
our Credit Facility. In view of current credit market conditions, we
anticipate that a new facility would reflect a lower total amount available and
higher interest rates than our current Credit Facility. Accordingly,
we anticipate incurring increased interest expense from the time that we enter
into a new credit facility. The terms and timing of a new credit
facility may vary based on market conditions.
Dividends
In order to qualify as a REIT, we are
required to distribute dividends (other than capital gain dividends) to our
stockholders in an amount at least equal to (A) the sum of (i) 90% of our "REIT
taxable income" (computed without regard to the dividends paid deduction and our
net capital gain), and (ii) 90% of the net income (after tax), if any, from
foreclosure property, minus (B) the sum of certain items of non-cash income. In
addition, if we dispose of any built-in gain asset during a recognition period,
we will be required to distribute at least 90% of the built-in gain (after tax),
if any, recognized on the disposition of such asset. Such distributions must be
paid in the taxable year to which they relate, or in the following taxable year
if declared before we timely file our tax return for such year and paid on or
before the first regular dividend payment after such declaration. In addition,
such distributions are required to be made pro rata, with no preference to any
share of stock as compared with other shares of the same class, and with no
preference to one class of stock as compared with another class except to the
extent that such class is entitled to such a preference. To the extent that we
do not distribute all of our net capital gain or do distribute at least 90%, but
less than 100% of our "REIT taxable income," as adjusted, we will be subject to
tax thereon at regular ordinary and capital gain corporate tax
rates. In addition, our credit facility has certain financial
covenants that limit the distribution of dividends paid during a fiscal quarter
to no more than 95% of our aggregate cumulative FFO as defined in the credit
agreement, unless a greater distribution is required to maintain REIT
status. The credit agreement defines FFO as net income (or loss) plus
depreciation and amortization and shall be adjusted for charges related to: (i)
restructuring our debt; (ii) redemption of preferred stock; (iii) litigation
charges up to $5.0 million; (iv) non-cash charges for accounts and notes
receivable up to $5.0 million; (v) non-cash compensation related expenses; (vi)
non-cash impairment charges;
and (vii) tax liabilities in an amount not to exceed $8.0
million.
During the first quarter of 2009, we
paid total dividends of $27.0 million.
On April
16, 2009, the Board of Directors declared a common stock dividend of $0.30 per
share to be paid May 15, 2009 to common stockholders of record on April 30,
2009. On April 16, 2009, the Board of Directors also declared the
regular quarterly dividends for our 8.375% Series D Cumulative Redeemable
Preferred Stock to stockholders of record on April 30, 2009. The
stockholders of record of the Series D Preferred Stock on April 30, 2009 will be
paid dividends in the amount of $0.52344 per preferred share on May 15,
2009. The liquidation preference for our Series D Preferred Stock is
$25.00 per share.
Liquidity
We believe our liquidity and various
sources of available capital, including cash from operations, our existing
availability under our Credit Facility and expected proceeds from mortgage
payoffs are more than adequate to finance operations, meet recurring debt
service requirements and fund future investments through the next twelve
months. As discussed above, we are currently evaluating opportunities
to replace or refinance our existing Credit Facility.
We
regularly review our liquidity needs, the adequacy of cash flow from operations,
and other expected liquidity sources to meet these needs. We believe
our principal short-term liquidity needs are to fund:
· normal
recurring expenses;
· debt
service payments;
· preferred
stock dividends;
· common
stock dividends; and
· growth
through acquisitions of additional properties.
The
primary source of liquidity is our cash flows from
operations. Operating cash flows have historically been determined
by: (i) the number of facilities we lease or have mortgages on; (ii) rental and
mortgage rates; (iii) our debt service obligations; and (iv) general and
administrative expenses. The timing, source and amount of cash flows
provided by financing activities and used in investing activities are sensitive
to the capital markets environment, especially to changes in interest
rates. Changes in the capital markets environment may impact the
availability of cost-effective capital and affect our plans for acquisition and
disposition activity. Current economic conditions reduced the
availability of cost-effective capital in recent quarters, and accordingly our
level of new investments has decreased. As economic conditions and
capital markets stabilize, we look forward to funding new investments as
conditions warrant. However, we cannot predict the timing or level of
future investments.
Cash and
cash equivalents totaled $10.2 million as of March 31, 2009, an increase of
$10.0 million as compared to the balance at December 31, 2008. The
following is a discussion of changes in cash and cash equivalents due to
operating, investing and financing activities, which are presented in our
Consolidated Statements of Cash Flows.
Operating
Activities –
Net cash flow from operating activities generated $45.4 million for the three
months ended March 31, 2009, as compared to $28.5 million for the same period in
2008, an increase of $16.9 million.
Investing
Activities – Net cash flow from investing activities was an outflow of
$39 thousand for the three months ended March 31, 2009, as compared to an
outflow of $9.5 million for the same period in 2008. The decrease in
cash outflow from investing activities relates primarily to i) the change in
acquisition activity, ii) the reduction in spending on capital
improvement projects and iii) a net increase in proceeds from the sale of
investments. In the first quarter of 2008, we acquired one facility
for $5.2 million compared to no acquisition during the first quarter of
2009. During the first quarter of 2009, we made $3.1 million in
capital improvements and renovation compared to $5.3 million in 2008, the
decrease relates primarily to the timing of projects.
Financing
Activities – Net cash flow from financing activities was an outflow of
$35.4 million for the three months ended March 31, 2009 as compared to an
outflow of $19.4 million for the same period in 2008. The increase in
cash outflow from financing activities of $15.9 million was primarily a result
of i) an increase in dividend payment of $4.6 million due to the issuance of
common stock during the second and third quarter of 2008, ii) an additional $3.5
million pay down of debt in 2009 compared to 2008, offset by a decrease in
dividend reinvestment proceeds of $9.9 million in 2009 compared to
2008.
We are exposed to various market risks,
including the potential loss arising from adverse changes in interest
rates. We do not enter into derivatives or other financial
instruments for trading or speculative purposes, but we seek to mitigate the
effects of fluctuations in interest rates by matching the term of new
investments with new long-term fixed rate borrowing to the extent
possible.
There were no material changes in our
market risk during the three months ended March 31, 2009. For
additional information, refer to Item 7A as presented in our annual report on
Form 10-K for the year ended December 31, 2008.
Disclosure controls and procedures (as
defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) are controls and other procedures that are designed to
provide reasonable assurance that the information that we are required to
disclose in the reports that we file or submit under the Exchange Act is
recorded, processed, summarized and reported within the time periods specified
in the SEC’s rules and forms, and that such information is accumulated and
communicated to our management, including our Chief Executive Officer and Chief
Financial Officer, as appropriate to allow timely decisions regarding required
disclosure.
In connection with the preparation of
this Form 10-Q, we evaluated the effectiveness of the design and operation of
our disclosure controls and procedures as of March 31, 2009. Based on
this evaluation, our Chief Executive Officer and Chief Financial Officer
concluded that our disclosure controls and procedures were effective at a
reasonable assurance level as of March 31, 2009.
There were no changes in our internal
control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)
under the Exchange Act) during the period covered by this report identified in
connection with the evaluation of our disclosure controls and procedures
described above that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
PART
II – OTHER
INFORMATION
See Note 9 – Litigation to the
Consolidated Financial Statements in Item 1 hereto, which is hereby incorporated
by reference in response to this item.
We filed our Annual Report on Form 10-K
for the year ended December 31, 2008 with the Securities and Exchange Commission
on March 2, 2009, which sets forth our risk factors in Item 1A therein. We have
not experienced any material changes from the risk factors previously described
therein.
Exhibit
No.
|
|
Description
|
10.1
|
|
Deferred
Stock Plan, dated January 20, 2009, and forms of related agreements
(Incorporated by reference to Exhibit 10.28 to the Company’s Annual Report
on Form 10-K, filed March 2, 2009).
|
31.1
|
|
Rule
13a-14(a)/15d-14(a) Certification of the Chief Executive
Officer.
|
31.2
|
|
Rule
13a-14(a)/15d-14(a) Certification of the Chief Financial
Officer.
|
32.1
|
|
Section
1350 Certification of the Chief Executive Officer.
|
32.2
|
|
Section
1350 Certification of the Chief Financial
Officer.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
OMEGA HEALTHCARE INVESTORS,
INC.
Registrant
Date: May
8,
2009 By: /S/ C. TAYLOR
PICKETT
C. Taylor Pickett
Chief Executive Officer
Date: May
8,
2009 By: /S/ ROBERT O.
STEPHENSON
Robert O. Stephenson
Chief Financial
Officer